HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Konstantinos Tziomalos Selected Research

Proprotein Convertase 9

1/2017The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins.
1/2017The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia.
1/2016Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
1/2015Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Konstantinos Tziomalos Research Topics

Disease

31Stroke (Strokes)
02/2023 - 07/2007
28Cardiovascular Diseases (Cardiovascular Disease)
03/2023 - 01/2006
27Ischemic Stroke
02/2023 - 01/2004
25Non-alcoholic Fatty Liver Disease
02/2023 - 05/2006
20Hypertension (High Blood Pressure)
12/2022 - 08/2005
18Obesity
01/2024 - 08/2005
18Type 2 Diabetes Mellitus (MODY)
03/2023 - 03/2008
17Coronary Disease (Coronary Heart Disease)
01/2019 - 01/2007
16Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
12/2020 - 01/2009
14Insulin Resistance
01/2023 - 02/2007
14Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 01/2007
13Overweight
12/2018 - 01/2010
12Weight Loss (Weight Reduction)
01/2022 - 01/2009
11Inflammation (Inflammations)
03/2023 - 04/2008
11Atherosclerosis
01/2023 - 04/2007
11Heart Failure
05/2020 - 02/2006
10Fibrosis (Cirrhosis)
03/2023 - 06/2005
10Body Weight (Weight, Body)
02/2023 - 05/2006
8Diabetes Mellitus
05/2020 - 06/2009
8Chronic Renal Insufficiency
01/2018 - 07/2009
8Chronic Hepatitis B
02/2015 - 06/2005
7Dyslipidemias (Dyslipidemia)
01/2019 - 09/2010
6Infections
02/2023 - 05/2015
6Atrial Fibrillation
11/2018 - 07/2007
6Vascular Diseases (Vascular Disease)
01/2011 - 11/2008
5Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2022 - 01/2016
4Hypoglycemia (Reactive Hypoglycemia)
10/2022 - 08/2020
4Diabetic Nephropathies (Diabetic Nephropathy)
07/2021 - 04/2015
4Acute Coronary Syndrome
05/2015 - 01/2009
4Liver Diseases (Liver Disease)
10/2014 - 10/2009
4Unstable Angina
09/2013 - 11/2007
4Myocardial Infarction
09/2013 - 11/2007
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2021 - 01/2018
3Alcoholic Fatty Liver
10/2021 - 11/2016
3Thrombosis (Thrombus)
05/2020 - 11/2010
3Hyperlipidemias (Hyperlipidemia)
01/2019 - 01/2006
3Liver Cirrhosis (Hepatic Cirrhosis)
09/2017 - 02/2006
3Vascular Calcification
05/2017 - 04/2008
3Essential Hypertension
02/2014 - 09/2006
3Glucose Intolerance
04/2013 - 01/2010
3Atherosclerotic Plaque (Atheroma)
07/2010 - 03/2007
3Abdominal Obesity
01/2010 - 02/2007
3Hyperaldosteronism (Conn Syndrome)
09/2008 - 01/2007
2Carotid Artery Diseases
03/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

48Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2021 - 01/2006
29LipidsIBA
01/2024 - 02/2007
27Glucose (Dextrose)FDA LinkGeneric
03/2023 - 08/2005
18LDL CholesterolIBA
03/2023 - 05/2006
15Triglycerides (Triacylglycerol)IBA
12/2022 - 05/2006
14Atorvastatin (Lipitor)FDA Link
09/2013 - 05/2006
13HDL CholesterolIBA
02/2023 - 01/2007
13oxidized low density lipoproteinIBA
12/2021 - 02/2007
12Metformin (Glucophage)FDA LinkGeneric
02/2020 - 05/2006
11Insulin (Novolin)FDA Link
10/2022 - 02/2007
10Orlistat (Xenical)FDA Link
12/2018 - 05/2006
10Antihypertensive Agents (Antihypertensives)IBA
01/2017 - 02/2007
9AdipokinesIBA
01/2022 - 01/2010
8AndrogensIBA
12/2018 - 02/2012
7Biomarkers (Surrogate Marker)IBA
02/2023 - 05/2006
7Hypoglycemic Agents (Hypoglycemics)IBA
10/2020 - 03/2008
7Uric Acid (Urate)IBA
06/2013 - 01/2007
6Glucagon-Like Peptide-1 Receptor AgonistsIBA
02/2023 - 01/2015
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2021 - 04/2007
6Lamivudine (Epivir)FDA Link
01/2010 - 06/2005
5SodiumIBA
03/2023 - 07/2019
5Angiotensin Receptor AntagonistsIBA
07/2022 - 02/2007
5AdiponectinIBA
01/2022 - 01/2012
5Transaminases (Aminotransferases)IBA
01/2022 - 11/2013
5Ezetimibe (Zetia)FDA Link
12/2017 - 02/2008
5Fibric Acids (Fibrates)IBA
01/2015 - 01/2006
5CholesterolIBA
04/2013 - 05/2006
4Sodium-Glucose Transporter 2 InhibitorsIBA
03/2023 - 01/2018
4Antiviral Agents (Antivirals)IBA
01/2023 - 03/2010
4Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2022 - 01/2010
4LeptinIBA
10/2019 - 01/2012
4ResistinIBA
10/2019 - 01/2012
4DiureticsIBA
01/2019 - 11/2010
4Pioglitazone (Actos)FDA Link
01/2018 - 03/2008
4Proprotein Convertase 9IBA
01/2017 - 01/2015
4IronIBA
01/2014 - 02/2006
4sibutramine (Meridia)FDA Link
10/2013 - 01/2009
4Hepatitis B e AntigensIBA
01/2010 - 06/2005
3EnzymesIBA
02/2023 - 01/2009
3LiraglutideFDA Link
01/2022 - 09/2017
3semaglutideIBA
01/2022 - 06/2017
3Spironolactone (Aldactone)FDA LinkGeneric
07/2021 - 01/2007
3Eplerenone (Inspra)FDA LinkGeneric
07/2021 - 01/2007
3C-Reactive ProteinIBA
01/2019 - 05/2006
3PCSK9 InhibitorsIBA
01/2017 - 01/2016
3Quinapril (Accupril)FDA LinkGeneric
01/2017 - 11/2011
3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2016 - 11/2005
3Dipeptidyl-Peptidase IV InhibitorsIBA
11/2015 - 04/2014
3Atenolol (Tenormin)FDA LinkGeneric
02/2014 - 09/2006
2Anti-Bacterial Agents (Antibiotics)IBA
02/2023 - 10/2016

Therapy/Procedure

19Therapeutics
01/2023 - 04/2006
11Secondary Prevention
12/2021 - 01/2006
7Drug Therapy (Chemotherapy)
08/2020 - 11/2005
5Glycemic Control
07/2022 - 01/2009
3Renal Dialysis (Hemodialysis)
01/2019 - 07/2009
3Bariatric Surgery
01/2018 - 01/2010